接口广告
摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methyl-N-octylbenzenesulfonamide

中文名称
——
中文别名
——
英文名称
2-methyl-N-octylbenzenesulfonamide
英文别名
——
2-methyl-N-octylbenzenesulfonamide化学式
CAS
——
化学式
C15H25NO2S
mdl
——
分子量
283.4
InChiKey
HWXQOUCAHYHCIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    19
  • 可旋转键数:
    9
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    54.6
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • Polyamide composite having two or more layers
    申请人:DEGUSSA AG
    公开号:US20020119272A1
    公开(公告)日:2002-08-29
    A good layer adhesion can be achieved in a composite having two or more layers wherein a layer I is obtained from a molding composition which has the following components: a) from 0 to 80 parts by weight of a polyamide selected from the group consisting of PA6, PA66, PA6/66 and a mixture thereof; b) from 0.05 to 100 parts by weight of a polyamine-polyamide copolymer; and c) from 0 to 80 parts by weight of a polyamide selected from the group consisting of PA11, PA12, PA612, PA1012, PA1212 and a mixture thereof; wherein a total of the parts by weight of components a), b) and c) is 100; wherein at least 20 parts by weight of components a) and b) is a monomer unit which is obtained from caprolactam and/or from a combination of hexamethylenediamine/adipic acid; and wherein at least 20 parts by weight of components b) and c) is a monomer unit which is obtained from &ohgr;-aminoundecanoic acid, laurolactam, a mixture of hexamethylenediamine and 1,12-dodecanedioic acid, a mixture of 1,10-decanediamine and 1,12-dodecanedioic acid, and/or a mixture of 1,12-dodecanediamine and 1,12-dodecanedioic acid.
    在具有两个或多个层的复合材料中可以实现良好的层间附着,其中层I是从模塑组合物中获得的,该组合物具有以下组分:a)从0到80重量份的聚酰胺,所述聚酰胺选自PA6,PA66,PA6 / 66和其混合物的群组成;b)从0.05到100重量份的聚酰胺-聚酰胺共聚物;以及c)从0到80重量份的聚酰胺,所述聚酰胺选自PA11,PA12,PA612,PA1012,PA1212和其混合物的群组成;其中组分a),b)和c)的重量份总和为100;其中至少20重量份的组分a)和b)是从己内酰胺和/或己二胺/己二酸的组合物中获得的单体单位;以及其中至少20重量份的组分b)和c)是从ω-十一酸,月桂内酯,己二胺和1,12-十二二酸的混合物,1,10-癸二胺和1,12-十二二酸的混合物,和/或1,12-十二二胺和1,12-十二二酸的混合物中获得的单体单位。
  • POLYAMIDE COMPOSITION CONTAINING ELECTRICALLY CONDUCTIVE CARBON
    申请人:HAEGER Harald
    公开号:US20130240799A1
    公开(公告)日:2013-09-19
    A polyamide composition which provides moldings having a significantly reduced percolation threshold and an improved electrical conductivity is provided. The composition contains a) at least 40 parts by weight of a polyamide; b) from 0.15 to 25 parts by weight of an electrically conductive carbon; c) from 0.3 to 8 parts by weight of an oligofunctional compound; and, optionally, d) conventional auxiliaries and additives, wherein the electrically conductive carbon comprises at least one of carbon nanotubes and graphene, the oligofunctional compound comprises at least one functional group reactive with reactive groups on a surface of the electrically conductive carbon and at least one functional group reactive with an end group of the polyamide, and the sum of the parts by weight of the components a) to d) is 100.
    提供了一种聚酰胺组合物,可提供具有显著降低渗透阈值和改善电导率的模塑件。该组合物包含a)至少40份重量的聚酰胺;b)0.15至25份重量的导电碳;c)0.3至8份重量的寡功能化合物;以及可选的d)传统辅助剂和添加剂,其中导电碳包括碳纳米管和石墨烯中的至少一种,寡功能化合物包括至少一种与导电碳表面上的反应性基团反应的功能性基团和至少一种与聚酰胺末端基团反应的功能性基团,组分a)到d)的重量份之和为100。
  • CURABLE COMPOSITION AND CATALYST COMPOSITION
    申请人:Kaneka Corporation
    公开号:EP2088173A1
    公开(公告)日:2009-08-12
    An object of the present invention is to provide a curable composition made mainly of an organic polymer having a reactive silicon group, exhibits a good curability without using any organic tin compound substantially, and gives a cured product having a sufficient strength; and to provide a catalyst composition. The object is solved by a curable composition, comprising a polymer (A) having a silicon-containing group which can be crosslinked by forming a siloxane bond, and a fluoride salt compound (B).
    本发明的目的是提供一种主要由具有活性基团的有机聚合物制成的可固化组合物,该组合物无需大量使用任何有机锡化合物即可表现出良好的可固化性,并使固化产品具有足够的强度;同时还提供一种催化剂组合物。本发明的目的是通过一种可固化组合物来实现的,该组合物包括一种具有含基团的聚合物(A),该聚合物可通过形成硅氧烷键而交联,以及一种化物盐化合物(B)。
  • Curable composition and catalyst composition
    申请人:KANEKA CORPORATION
    公开号:EP2302000A1
    公开(公告)日:2011-03-30
    An object of the present invention is to provide a curable composition made mainly of an organic polymer having a reactive silicon group, exhibits a good curability without using any organic tin compound substantially, and gives a cured product having a sufficient strength; and to provide a catalyst composition. The object is solved by a curable composition, comprising a polymer (A) having a silicon-containing group which can be crosslinked by forming a siloxane bond, and a fluoride salt compound (B).
    本发明的目的是提供一种主要由具有活性基团的有机聚合物制成的可固化组合物,该组合物无需大量使用任何有机锡化合物即可表现出良好的可固化性,并使固化产品具有足够的强度;同时还提供一种催化剂组合物。本发明的目的是通过一种可固化组合物来实现的,该组合物包括一种具有含基团的聚合物(A),该聚合物可通过形成硅氧烷键而交联,以及一种化物盐化合物(B)。
  • CURING COMPOSITIONS
    申请人:Aqdot Ltd
    公开号:EP3095804A1
    公开(公告)日:2016-11-23
    Provided are epoxy compositions comprising a cucurbituril in complex with a curative, and methods for curing the epoxy composition. The curative is reactive with an epoxy compound, and the curative may be a cure accelerator or a cure hardener. The invention also provides cured resins obtained or obtainable from the epoxy compositions. Also provided are complexes of a cucurbituril with a curative.
    本文提供了包含葫芦与固化剂复合物的环氧组合物,以及固化环氧组合物的方法。固化剂与环氧化合物反应,固化剂可以是固化促进剂或固化硬化剂。本发明还提供了从环氧组合物中获得或可获得的固化树脂。本发明还提供了葫芦与固化剂的复合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫